Jane A. Gross

Insider Reports History

Entity
Individual
Location
2401 4 Th Avenue, Suite 1050, Seattle, WA
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jane A. Gross:

Stock Role Class Num Shares Value Price $ Report Date Ownership
aTYR PHARMA INC Director Stock Option (right to buy) 24K May 22, 2024 Direct

Insider Reports Filed by Jane A. Gross

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LIFE aTYR PHARMA INC May 22, 2024 1 $0 4 May 23, 2024 Director
LIFE aTYR PHARMA INC May 17, 2023 1 $0 4 May 19, 2023 Director
LIFE aTYR PHARMA INC Apr 26, 2023 2 $0 4 Apr 28, 2023 Director
BCTX BriaCell Therapeutics Corp. Aug 1, 2022 0 $0 3 Aug 1, 2022 Director
LIFE aTYR PHARMA INC Apr 26, 2022 1 $0 4 Apr 28, 2022 Director